|
Volumn 100, Issue 4, 2003, Pages 2134-2139
|
The effect of anandamide on prolactin secretion is modulated by estrogen
|
Author keywords
Cannabinoid receptors; CB1 antagonist; Dopamine; Dopamine receptors; Estradiol
|
Indexed keywords
3,4 DIHYDROXYPHENYLACETIC ACID;
ANANDAMIDE;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR ANTAGONIST;
DOPAMINE;
ESTROGEN;
PROLACTIN;
TETRAHYDROCANNABINOL;
ADENOHYPOPHYSIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN THIRD VENTRICLE;
CONTROLLED STUDY;
DOPAMINE METABOLISM;
DOPAMINE RELEASE;
DOPAMINERGIC SYSTEM;
DRUG INHIBITION;
FEMALE;
HORMONE RESPONSE;
HYPOTHALAMUS PERIVENTRICULAR NUCLEUS;
IMMUNOCYTOCHEMISTRY;
MALE;
NONHUMAN;
OVARIECTOMY;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PROLACTIN RELEASE;
PROTEIN LOCALIZATION;
RAT;
RECEPTOR AFFINITY;
SYNAPTIC TRANSMISSION;
3,4-DIHYDROXYPHENYLACETIC ACID;
ANIMALS;
ARACHIDONIC ACIDS;
DOPAMINE;
ESTROGENS;
FEMALE;
HYPOTHALAMUS;
MALE;
NEURONS;
OVARIECTOMY;
POLYUNSATURATED ALKAMIDES;
PROLACTIN;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTOR, CANNABINOID, CB2;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
ANIMALIA;
CANNABIS SATIVA;
|
EID: 0037452602
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.0437924100 Document Type: Article |
Times cited : (34)
|
References (26)
|